|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Villanueva A, Hernandez-Gea V and Llovet
JM: Medical therapies for hepatocellular carcinoma: A critical view
of the evidence. Nat Rev Gastroenterol Hepatol. 10:34–42. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhao C, Wang W, Yu W, Jou D, Wang Y, Ma H,
Xiao H, Qin H, Zhang C, Lü J, et al: A novel small molecule STAT3
inhibitor, LY5, inhibits cell viability, colony formation, and
migration of colon and liver cancer cells. Oncotarget.
7:12917–12926. 2016.PubMed/NCBI
|
|
4
|
Zhang Z, Mao H, Du X, Zhu J, Xu Y, Wang S,
Xu X, Ji P, Yu Y, Cao B, et al: A novel small molecule agent
displays potent anti-myeloma activity by inhibiting the JAK2-STAT3
signaling pathway. Oncotarget. 7:9296–9308. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lanton T, Shriki A, Nechemia-Arbely Y, et
al: IL6-Dependent genomic instability heralds accelerated
carcinogenesis following liver regeneration on a background of
chronic hepatitis. Hepatology. 65:1600–1611. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Aggarwal BB, Sethi G, Ahn KS, Sandur SK,
Pandey MK, Kunnumakkara AB, Sung B and Ichikawa H: Targeting
signal-transducer-and-activator-of-transcription-3 for prevention
and therapy of cancer: modern target but ancient solution. Ann N Y
Acad Sci. 1091:151–169. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhao H, Guo Y, Li S, Han R, Ying J, Zhu H,
Wang Y, Yin L, Han Y, Sun L, et al: A novel anti-cancer agent
Icaritin suppresses hepatocellular carcinoma initiation and
malignant growth through the IL-6/Jak2/Stat3 pathway. Oncotarget.
6:31927–31943. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Khorasany AR and Hosseinzadeh H:
Therapeutic effects of saffron (Crocus sativus L.) in digestive
disorders: a review. Iran J Basic Med Sci. 19:455–469.
2016.PubMed/NCBI
|
|
9
|
Kim SH, Lee JM, Kim SC, Park CB and Lee
PC: Proposed cytotoxic mechanisms of the saffron carotenoids crocin
and crocetin on cancer cell lines. Biochem Cell Biol. 92:105–111.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Asdaq SM and Inamdar MN: Potential of
Crocus sativus (saffron) and its constituent, crocin, as
hypolipidemic and antioxidant in rats. Appl Biochem Biotechnol.
162:358–372. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ordoudi SA, Befani CD, Nenadis N, Koliakos
GG and Tsimidou MZ: Further examination of antiradical properties
of Crocus sativus stigmas extract rich in crocins. J Agric Food
Chem. 57:3080–3086. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu GL, Yu SQ, Gong ZN and Zhang SQ: Study
of the effect of crocin on rat experimental hyperlipemia and the
underlying mechanisms. Zhongguo Zhong Yao Za Zhi. 30:369–372.
2005.(In Chinese). PubMed/NCBI
|
|
13
|
Wang Y, Han T, Zhu Y, Zheng CJ, Ming QL,
Rahman K and Qin LP: Antidepressant properties of bioactive
fractions from the extract of Crocus sativus L. J Nat Med.
64:24–30. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nam KN, Park YM, Jung HJ, Lee JY, Min BD,
Park SU, Jung WS, Cho KH, Park JH, Kang I, et al: Anti-inflammatory
effects of crocin and crocetin in rat brain microglial cells. Eur J
Pharmacol. 648:110–116. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu GL, Li G, Ma HP, Zhong H, Liu F and Ao
GZ: Preventive effect of crocin in inflamed animals and in
LPS-challenged RAW 264.7 cells. J Agric Food Chem. 57:8325–8330.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu HJ, Zhong R, Zhao YX, Li XR, Lu Y, Song
AQ, Pang XY, Yao RY and Sun LR: Proliferative inhibition and
apoptotic induction effects of crocin on human leukemia HL-60 cells
and their mechanisms. Zhongguo Shi Yan Xue Ye Xue Za Zhi.
18:887–892. 2010.(In Chinese). PubMed/NCBI
|
|
17
|
Aung HH, Wang CZ, Ni M, Fishbein A,
Mehendale SR, Xie JT, Shoyama CY and Yuan CS: Crocin from Crocus
sativus possesses significant anti-proliferation effects on human
colorectal cancer cells. Exp Oncol. 29:175–180. 2007.PubMed/NCBI
|
|
18
|
Chryssanthi DG, Lamari FN, Iatrou G,
Pylara A, Karamanos NK and Cordopatis P: Inhibition of breast
cancer cell proliferation by style constituents of different Crocus
species. Anticancer Res. 27:357–362. 2007.PubMed/NCBI
|
|
19
|
Zhao P, Luo CL, Wu XH, Hu HB, Lv CF and Ji
HY: Proliferation apoptotic influence of crocin on human bladder
cancer T24 cell line. Zhongguo Zhong Yao Za Zhi. 33:1869–1873.
2008.(In Chinese). PubMed/NCBI
|
|
20
|
Mashmoul M, Azlan A, Mohtarrudin N, Mohd
Yusof BN, Khaza'ai H, Khoo HE, Farzadnia M and Boroushaki MT:
Protective effects of saffron extract and crocin supplementation on
fatty liver tissue of high-fat diet-induced obese rats. BMC
Complement Altern Med. 16:4012016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Deng J, Grande F and Neamati N: Small
molecule inhibitors of Stat3 signaling pathway. Curr Cancer Drug
Targets. 7:91–107. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu D, Ye T, Xiang Y, Shi Z, Zhang J, Lou
B, Zhang F, Chen B and Zhou M: Quercetin inhibits
epithelial-mesenchymal transition, decreases invasiveness and
metastasis, and reverses IL-6 induced epithelial-mesenchymal
transition, expression of MMP by inhibiting STAT3 signaling in
pancreatic cancer cells. Onco Targets Ther. 10:4719–4729. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang L, Cao L, Wang H, Liu B, Zhang Q,
Meng Z, Wu X, Zhou Q and Xu K: Cancer-associated fibroblasts
enhance metastatic potential of lung cancer cells through
IL-6/STAT3 signaling pathway. Oncotarget. 8:76116–76128.
2017.PubMed/NCBI
|
|
24
|
Zhao X, Huang L, Xu W and Chen X, Shen Y,
Zeng W and Chen X: Physapubescin B inhibits tumorgenesis and
circumvents taxol resistance of ovarian cancer cells through STAT3
signaling. Oncotarget. 8:70130–70141. 2017.PubMed/NCBI
|
|
25
|
Zhang YX, Yan L, Liu GY, Chen WJ, Gong WH
and Yu JM: Inhibition of janus kinase 2 by compound AG490
suppresses the proliferation of MDA-MB-231 cells via up-regulating
SARI (suppressor of AP-1, regulated by IFN). Iran J Basic Med Sci.
18:599–603. 2015.PubMed/NCBI
|
|
26
|
Fan LC, Teng HW, Shiau CW, Tai WT, Hung
MH, Yang SH, Jiang JK and Chen KF: Pharmacological targeting
SHP-1-STAT3 signaling is a promising therapeutic approach for the
treatment of colorectal cancer. Neoplasia. 17:687–696. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yu CL, Meyer DJ, Campbell GS, Larner AC,
Carter-Su C, Schwartz J and Jove R: Enhanced DNA-binding activity
of a Stat3-related protein in cells transformed by the Src
oncoprotein. Science. 269:81–83. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim BH, Won C, Lee YH, Choi JS, Noh KH,
Han S, Lee H, Lee CS, Lee DS, Ye SK and Kim MH: Sophoraflavanone G
induces apoptosis of human cancer cells by targeting upstream
signals of STATs. Biochem Pharmacol. 86:950–959. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Darnell JE Jr: STATs and gene regulation.
Science. 277:1630–1635. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang T, Li S, Li J, Yin F, Hua Y, Wang Z,
Lin B, Wang H, Zou D, Zhou Z, et al: Natural product
pectolinarigenin inhibits osteosarcoma growth and metastasis via
SHP-1-mediated STAT3 signaling inhibition. Cell Death Dis.
7:e24212016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lee JH, Kim C, Baek SH, Ko JH, Lee SG,
Yang WM, Um JY, Sethi G and Ahn KS: Capsazepine inhibits JAK/STAT3
signaling, tumor growth, and cell survival in prostate cancer.
Oncotarget. 8:17700–17711. 2017.PubMed/NCBI
|
|
32
|
Baek SH, Lee JH, Ko JH, Lee H, Nam D, Lee
SG, Yang WM, Um JY, Lee J, Kim SH, et al: Ginkgetin blocks
constitutive STAT3 activation and induces apoptosis through
induction of SHP-1 and PTEN tyrosine phosphatases. Phytother Res.
30:567–576. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu X, Xiao Q, Bai X, Yu Z, Sun M, Zhao H,
Mi X, Wang E, Yao W, Jin F, et al: Activation of STAT3 is involved
in malignancy mediated by CXCL12-CXCR4 signaling in human breast
cancer. Oncol Rep. 32:2760–2768. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pfeiffer M, Hartmann TN, Leick M, Catusse
J, Schmitt-Graeff A and Burger M: Alternative implication of CXCR4
in JAK2/STAT3 activation in small cell lung cancer. Br J Cancer.
100:1949–1956. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tang Y, Guo Q, Zhi Y, Jin X, Xia B, Guo S,
Tian C and Zhang Y: Role of CXCR4/STAT3 in mesenchymal stromal
cell-mediated drug resistance of acute leukemia cells. Zhonghua Xue
Ye Xue Za Zhi. 37:119–123. 2016.(In Chinese). PubMed/NCBI
|
|
36
|
Yahata Y, Shirakata Y, Tokumaru S,
Yamasaki K, Sayama K, Hanakawa Y, Detmar M and Hashimoto K: Nuclear
translocation of phosphorylated STAT3 is essential for vascular
endothelial growth factor-induced human dermal microvascular
endothelial cell migration and tube formation. J Biol Chem.
278:40026–40031. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Pandey MK, Sung B and Aggarwal BB:
Betulinic acid suppresses STAT3 activation pathway through
induction of protein tyrosine phosphatase SHP-1 in human multiple
myeloma cells. Int J Cancer. 127:282–292. 2010.PubMed/NCBI
|
|
38
|
Yu H, Pardoll D and Jove R: STATs in
cancer inflammation and immunity: A leading role for STAT3. Nat Rev
Cancer. 9:798–809. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
39
|
Banville D, Stocco R and Shen SH: Human
protein tyrosine phosphatase 1C (PTPN6) gene structure: Alternate
promoter usage and exon skipping generate multiple transcripts.
Genomics. 27:165–173. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tsui HW, Hasselblatt K, Martin A, Mok SC
and Tsui FW: Molecular mechanisms underlying SHP-1 gene expression.
Eur J Biochem. 269:3057–3064. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wu C, Sun M, Liu L and Zhou GW: The
function of the protein tyrosine phosphatase SHP-1 in cancer. Gene.
306:1–12. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wu C, Guan Q, Wang Y, Zhao ZJ and Zhou GW:
SHP-1 suppresses cancer cell growth by promoting degradation of JAK
kinases. J Cell Biochem. 90:1026–1037. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Morikawa T, Baba Y, Yamauchi M, Kuchiba A,
Nosho K, Shima K, Tanaka N, Huttenhower C, Frank DA, Fuchs CS and
Ogino S: STAT3 expression, molecular features, inflammation
patterns, and prognosis in a database of 724 colorectal cancers.
Clin Cancer Res. 17:1452–1462. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wang SW and Sun YM: The IL-6/JAK/STAT3
pathway: Potential therapeutic strategies in treating colorectal
cancer (Review). Int J Oncol. 44:1032–1040. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Iwamaru A, Szymanski S, Iwado E, Aoki H,
Yokoyama T, Fokt I, Hess K, Conrad C, Madden T, Sawaya R, et al: A
novel inhibitor of the STAT3 pathway induces apoptosis in malignant
glioma cells both in vitro and in vivo. Oncogene. 26:2435–2444.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Michaud-Levesque J, Bousquet-Gagnon N and
Beliveau R: Quercetin abrogates IL-6/STAT3 signaling and inhibits
glioblastoma cell line growth and migration. Exp Cell Res.
318:925–935. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Sandur SK, Pandey MK, Sung B and Aggarwal
BB: 5-hydroxy-2-methyl-1,4-naphthoquinone, a vitamin K3 analogue,
suppresses STAT3 activation pathway through induction of protein
tyrosine phosphatase, SHP-1: Potential role in chemosensitization.
Mol Cancer Res. 8:107–118. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Xie T, Ren HY, Lin HQ, Mao JP, Zhu T, Wang
SD and Ye ZM: Sinomenine prevents metastasis of human osteosarcoma
cells via S phase arrest and suppression of tumor-related
neovascularization and osteolysis through the CXCR4-STAT3 pathway.
Int J Oncol. 48:2098–2112. 2016. View Article : Google Scholar : PubMed/NCBI
|
